Annika
Annika Algars, Kuusisto FI
Patent application number | Description | Published |
---|---|---|
20110217296 | METHOD FOR SELECTING PATIENTS FOR TREATMENT WITH AN EGFR INHIBITOR - The present invention relates to cancer diagnostics and therapies and to the detection of alterations in cancer cells that are diagnostic, prognostic or predictive. In particular, the present invention provides a method for detecting and analyzing whether a patient suffering from a cancer is responsive to the treatment with an EGFR inhibitor. In the method, a tissue section from a cancer sample is subjected to assays based on immunohistochemistry and enzymatic metallography. | 09-08-2011 |
Annika Birkler, Malmo SE
Patent application number | Description | Published |
---|---|---|
20090034232 | FUEL DISPENSING UNIT HOUSING - A housing for a fuel dispensing unit comprises a top part, a bottom part and at least one column extending between the bottom part and the top part. Said bottom part comprises a light emitting device arranged to emit light, and said top part comprises a light directing device for directing the emitted light towards the bottom part. | 02-05-2009 |
20120199242 | KIT OF PARTS FOR A MODULE HAVING A NOZZLE BOOT AND A FUEL DISPENSING UNIT HAVING A NOZZLE MODULE ASSEMBLED WITH SUCH A KIT OF PARTS - This invention relates to a kit of parts ( | 08-09-2012 |
20120205394 | ELECTRONICS MODULE FOR A FUEL DISPENSING UNIT - It is presented an electronics module ( | 08-16-2012 |
20120211524 | MODULE WITH NOZZEL BOOT FOR A FUEL DESPENSING UNIT - The invention relates to a nozzle module ( | 08-23-2012 |
20120267370 | FUEL DISPENSING UNIT WITH HINGED DOOR - The present invention relates to a fuel dispensing unit ( | 10-25-2012 |
20120319957 | TRANSACTION TERMINAL COMPRISING A VIEW SHIELD - A transaction terminal is provided. The transaction terminal comprises a display configured to present information to a user of the terminal, a keypad which is separate from the display and configured to receive input from the user, and a view shield. The view shield is arranged to prevent a view of at least a part of the keypad in a first direction, and allow a view through the view shield of at least a part of the display in a second direction, wherein the second direction is different from the first direction. | 12-20-2012 |
20130001246 | FUEL DISPENING UNIT FOR REFUELLING VEHICLES AND A METHOD FOR ASSEMBLING SUCH A FUEL DISPENSING UNIT - The invention relates to a fuel dispensing unit ( | 01-03-2013 |
20140174601 | KIT OF PARTS FOR A MODULE HAVING A NOZZLE BOOT AND A FUEL DISPENSING UNIT HAVING A NOZZLE MODULE ASSEMBLED WITH SUCH A KIT OF PARTS - This invention relates to a kit of parts ( | 06-26-2014 |
20140338786 | Module with Nozzle Boot for a Fuel Dispensing Unit - The invention relates to a nozzle module ( | 11-20-2014 |
20150353341 | Kit of Parts for a Module Having a Nozzle Boot and a Fuel Dispensing Unit Having a Nozzle Module Assembled with Such a Kit of Parts - This invention relates to a kit of parts that can include top plates, gable cover plates, gable structures each comprising a nozzle boot, side cover plates, and side structures each comprising a nozzle boot. The kit of parts is suitable for assembling a nozzle module according to any one of three configurations. The invention also relates to a fuel dispensing unit for refueling vehicles. | 12-10-2015 |
Annika Bjore, Stenungsund SE
Patent application number | Description | Published |
---|---|---|
20090326221 | New oxabispidine compunds useful in the treatment of cardiac arrhythmias - There is provided compounds of formula I, | 12-31-2009 |
Annika Brobach, Malmo SE
Patent application number | Description | Published |
---|---|---|
20090259990 | Mobile Device Software Management Method and Apparatus - Mobile device software is managed by providing an interface between a plurality of software module handlers and a plurality of software modules. The interface is invoked responsive to a software module event such as the installation, removal, activation or modification of a software module. The interface identifies the software module and a corresponding attribute list associated with the software module event. The attribute list specifies one or more actions to be taken by at least one of the software module handlers that enable the identified software module to provide one or more functions when invoked. The attribute list is provided to each software module handler identified in the list and each action specified in the list is taken by the corresponding software module handler. This way, the interface reliably manages the different software modules without being aware of the particular functions provided by the modules or the specific actions taken by the handlers. | 10-15-2009 |
Annika Eisenschmidt, Leipzig DE
Patent application number | Description | Published |
---|---|---|
20150159150 | METHOD FOR ACTIVATING A SURFACE BY INCREASING THE HYDROPHILICITY AND/OR FOR BINDING TARGET STRUCTURES - The invention relates to a method for activating a surface by increasing the hydrophilicity and/or for binding target structures, particularly selected from the group consisting of proteins, cellular proteins, proteins, cells, carbohydrates, peptides and amino acids. It also relates to the use of an oxidoreductase for activating a surface for the mentioned bonds and to corresponding activated surfaces. | 06-11-2015 |
Annika Frey, Hanau DE
Patent application number | Description | Published |
---|---|---|
20140256974 | PROCESS FOR PREPARING TRIALKYLGALLIUM COMPOUNDS - The invention relates to a process for preparing trialkylgallium compounds of the general formula R | 09-11-2014 |
20140287141 | Process for Preparing Trialkyl Compounds of Metals of Group IIIA - The invention relates to a process for preparing trialkylmetal compounds of the general formula R | 09-25-2014 |
Annika Hagendorf, Hattersheim DE
Patent application number | Description | Published |
---|---|---|
20140286933 | STABLE IGG4 BASED BINDING AGENT FORMULATIONS - The present invention provides stable pharmaceutical antibody formulations, including liquid drug product formulations and lyophilized drug product formulations, comprising an IgG4 binding agent and a citrate buffer, wherein the pH of the formulation is at or below both pH 6 and the pI of the binding agent. The formulations can be used in the treatment of chronic bowel diseases or rheumatoid arthritis. | 09-25-2014 |
Annika Hagendorf, Frankfurt Am Main DE
Patent application number | Description | Published |
---|---|---|
20120252724 | INSULIN PREPARATIONS CONTAINING METHIONINE - The invention relates to an aqueous pharmaceutical formulation having insulin, an insulin analog, or an insulin derivative, and methionine; and to the production thereof, to the use thereof for treating diabetes mellitus, and to a medication for treating diabetes mellitus. | 10-04-2012 |
20120295846 | PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1 AGONIST, AN INSULIN AND METHIONINE - A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate. | 11-22-2012 |
Annika Halwe-Bommelmann, Rahden DE
Patent application number | Description | Published |
---|---|---|
20110175346 | RIGID FOAM ENVELOPMENT OF THE CONNECTIONS OF PIPES - The invention relates to the envelopment of a connection of at least two pipes or parts thereof by an open-celled rigid foam, the production of such an envelope and also the use of open-celled rigid foam for protecting connections of two pipes. | 07-21-2011 |
Annika Halwe-Bommelmann, Rahden-Varl DE
Patent application number | Description | Published |
---|---|---|
20130048137 | PROCESS FOR PRODUCING INSULATED PIPES HAVING IMPROVED PROPERTIES - The present invention relates to a process for producing insulated pipes, the use of a polyurethane system comprising an isocyanate component (a), a polyol mixture (b) and at least one catalyst for producing insulated pipes, wherein the cream time for the polyurethane system is less than the time for introduction of the polyurethane system into the pipe, the use of specific amines as catalyst in a polyurethane system for producing insulated pipes and also an insulated pipe which can be obtained by the process of the invention. | 02-28-2013 |
Annika Hasselstrom, Vilbdjerg DK
Patent application number | Description | Published |
---|---|---|
20090272763 | DISPENSER WITH A BAG INSIDE AND METHOD FOR MANUFACTURING OF THE SAME - A dispenser where a container ( | 11-05-2009 |
Annika Hofstetter Olsson, New York, NY US
Patent application number | Description | Published |
---|---|---|
20110008258 | METHODS RELATING TO BREATHING DISORDERS - Methods for treating breathing disorders by inhibition of the induced PGE | 01-13-2011 |
Annika Johann-Krone, Stemwede-Dielingen Dielingen DE
Patent application number | Description | Published |
---|---|---|
20120302652 | HIGH RESILIENCE POLYURETHANE FOAMS COMPRISING CASTOR OIL - A process for producing high resilience flexible polyurethane foams. The process includes forming a mixture of (a) isocyanate prepolymer, (b) polymeric compounds having isocyanate-reactive groups, (c) castor oil, (d) optionally chain-extending and/or crosslinking agents, (e) catalysts, (f) blowing agents, and optionally (g) additives, and reacting the mixture to form the flexible polyurethane foam. More than 5 wt % of (c) is used, based on the total weight of components (b) to (g), and (a) is obtained by mixing diphenylmethane diisocyanate (a1) and polyol 1 (a2) and also optionally further polyols, chain extenders and/or crosslinkers, where (a2) includes a polyalkylene oxide polyol having a hydroxyl number of 30 to 60, an average functionality of 2.3 to 3.2 and a propylene oxide fraction, based on the alkylene oxide content, of 70 to 100 wt %. A polyurethane foam obtained by the process, and the use of such a foam as an auto seat. | 11-29-2012 |
Annika Kaisdotter Andersson, Vasteras SE
Patent application number | Description | Published |
---|---|---|
20130231871 | MULTIFUNCTIONAL BREATH ANALYZER - A multifunctional breath analyzer includes a receptor unit for receiving a breath sample from a test subject, a sensing unit providing a signal corresponding to the concentration of at least one volatile substance within the sample, elements for providing a signal indicative of the dilution of the breath sample, and an analyzing unit/processing unit for the identification and quantification of the volatile substance of the breath sample. The signal processing unit is configured to perform at least two different calculations for the quantification, and the signal processing unit is also configured to automatically display the result of a selected calculation, the selection being based on the signal indicating dilution. | 09-05-2013 |
20150219620 | BREATH TEST SYSTEM - A breath test system is provided comprising a sensor unit configured to sense the presence or concentration of a volatile substance present in air flowing through a predefined inlet area, and generate a signal corresponding to the concentration of said substance. Also provided is an apparatus configured to detect the presence of a person in the vicinity of said input area, and registering said presence, and configured to respond by delivering an output. This apparatus includes a unit configured to call for immediate attention of said person, and upon registration of the presence of said person, provide instructions to said person to direct an expiratory air flow towards said inlet area. An analyzer to determine breath substance concentration of said person is also provided, the determination based on said signal corresponding to the substance concentration. | 08-06-2015 |
Annika Kers, Macclesfield GB
Patent application number | Description | Published |
---|---|---|
20130210837 | Compounds and Their Use as BACE Inhibitors - The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration. | 08-15-2013 |
20150133471 | COMPOUNDS AND THEIR USE AS BACE INHIBITORS - The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration. | 05-14-2015 |
Annika Kotovuori, Vantaa FI
Patent application number | Description | Published |
---|---|---|
20110143373 | METHOD OF EVALUATING THE INTEGRITY OF THE PLASMA MEMBRANE OF CELLS BY DETECTING GLYCANS FOUND ONLY INTRACELLULARLY - The invention describes novel reagents that can be applied for analysis of the quality of human cells. The method evaluates the integrity of the plasma membrane of the cells by detecting novel glyco structures found only intracellularly. The method can be applied, for example, to demonstrate exposure of therapeutic cell preparation to potentially harmful conditions. It can also be used as a quality control tool in methods in which intact cell membrane is essential and it can be applied in separation of damaged cells from non- damaged. | 06-16-2011 |
Annika Leifert, Aachen DE
Patent application number | Description | Published |
---|---|---|
20080241258 | TREATMENT OF DISEASES WITH NANOPARTICLES HAVING A SIZE-DEPENDENT CYTOTOXICITY - The present invention relates to the use of at least one gold nanocluster compound in the manufacture of a pharmaceutical composition or medicament for the prophylactic and/or therapeutic (curative) treatment of a disease, especially a tumor and/or cancer disease. The gold nanocluster compound having a defined particle size, especially a defined size of the core of said gold nanocluster compound, the size ranging from 0.5 nm to 10 nm, the outer limits of this range being included. Especially, the gold nanocluster compounds used possess size-dependent cytotoxic properties, stimulating or inducing cellular death when treating and/or contacting respective cells, especially tumor and/or cancer cells, with the gold nanocluster compounds either via apoptosis or via necrosis, depending on the respective gold cluster size or core size. | 10-02-2008 |
20110300532 | CONTROL OF THE TOXICITY OF GOLD NANOPARTICLES - The present invention relates to gold nanocluster compounds, especially gold nanoparticles, having a reduced toxicity, especially cytotoxicity, which are preferably appropriate for use in medical diagnostics such as medical imaging (e.g. X-ray, CT etc.), said gold nanocluster compounds comprising a core of at least one gold atom and at least one ligand bound to said core, wherein the reduction of toxicity, especially cytotoxicity, of said gold nanocluster compound is controlled and/or adjusted via its ligand structure and/or its ligand chemistry. | 12-08-2011 |
Annika Mannes, Hamburg DE
Patent application number | Description | Published |
---|---|---|
20100260689 | REDUCING SHAVING FREQUENCY - The invention describes the use of acidic aluminum compounds that in cosmetic preparations result in hair softening and a reduction of the shaving frequency. | 10-14-2010 |
Annika Mayra-Makinen, Helsinki FI
Patent application number | Description | Published |
---|---|---|
20140286920 | Prevention and Diagnosis of Visceral Fat - The invention is based on a correlation observed between visceral fat and gut flora. The invention relates to a product increasing the relative proportion of | 09-25-2014 |
20140301995 | Raising and Diagnosing of Serotonin Level - The invention is based on a correlation observed between serotonin level and intestinal flora. The invention relates to a relative proportion of bifidobacteria in the intestine and in particular to a product increasing the ratio of bifidobacteria to Clostridia, to be used for raising the serotonin level. The invention also relates to a method for estimating a health risk associated with serotonin depletion by determining a relative proportion between bifidobacteria or Clostridia in the intestine or their ratio to one another. The invention further relates to a method for selecting a form of therapy for raising the serotonin level by determining a relative proportion between bifidobacteria or Clostridia in the intestine or their ratio to one another. | 10-09-2014 |
Annika Mueller, Geislingen DE
Patent application number | Description | Published |
---|---|---|
20160120573 | Sealing device for sealing a lead-through for a medical instrument - A sealing device ( | 05-05-2016 |
Annika Müller, Geislingen DE
Patent application number | Description | Published |
---|---|---|
20150208903 | Endoscopic Instrument - Endoscopic instrument including first, second and third portions, a first main hinge with a first main-hinge part, a further first main-hinge part and a first sub-hinge, a second main hinge with a second main-hinge part, a further second main-hinge part and a second sub-hinge, and a rigid main pressure rod. The first and second portions are connected via the first main hinge, such that they can be angled. The first and third portions are connected via the second main hinge such that they can be angled. The main pressure rod is coupled to the first and second sub-hinges, so that displacement of the first main hinge by angling the second portion relative to the first portion transmits a force, via the main pressure rod, to the second main hinge and causes there an angling of the third portion relative to the first portion. | 07-30-2015 |
Annika Naeslund, Bromma SE
Patent application number | Description | Published |
---|---|---|
20100016935 | MEDICAL IMPLANTABLE LEAD - A implantable lead an elongate body including a flexible insulating tube, and a tubular conductor layer formed of multiple separate strip conductors, which are arranged at the outer surface of the insulating tube and extend along the length thereof. | 01-21-2010 |
20100114279 | MEDICAL IMPLANTABLE LEAD - A medical implantable lead has a proximal end and a distal end, and a flexible flat elongate body. The elongate body includes a layer of strip conductors extending along the length of the flat elongate body, a top insulating layer, and a bottom insulating layer. The layer of strip conductors is sealingly enclosed between the top and bottom insulating layers, and at least a major portion of the flat elongate body is twisted into an elongate helical portion having a central cavity extending longitudinally of the helical portion. | 05-06-2010 |
20100168806 | DEVICE AND METHOD FOR TREATING CARDIAC TISSUE OF A HEART OF A PATIENT WITH THERAPEUTIC LIGHT USING PHOTOBIOMODULATION - For treatment of cardiac tissue of a heart of a patient with therapeutic light using an implantable medical device connectable to at least one medical lead carrying electrodes and at least one fixation element that fixes the lead at a fixation area of the cardiac tissue, therapeutic light is emitted toward the at least one fixation area of cardiac tissue and/or toward a contact area between the at least one electrode and cardiac tissue using an intracorporeal light emitter. | 07-01-2010 |
20100280563 | DEVICE AND METHOD FOR DETECTING AND TREATING A MYOCARDIAL INFARCTION USING PHOTOBIOMODULATION - In an implantable medical device and a method for treating cardiac tissue of a heart of a patient with therapeutic light, a myocardial infarction is detected and a location the myocardial infarction is identified. A therapy session is initiated by selectively activating one or more of a number of light emitting units arranged in at least one medical lead connectable to the implantable medical device, to emit therapeutic light toward the detected location of the myocardial infarction upon detection of an occurrence of the myocardial infarction. | 11-04-2010 |
20110040291 | TISSUE STIMULATING DEVICE AND METHOD - A tissue stimulating device that provides a biological stimulation of tissue has a release surface adapted for arrangement adjacent to a tissue to be stimulated. An agent reservoir of the device includes an ionic agent capable of causing a stimulation if present at sufficient high extracellular concentration close to the tissue. An agent releaser is provided in the device for releasing a selected amount of the ionic agent from the agent reservoir to an outside of the release surface at a stimulation occasion for stimulating the tissue. The ionic agent will cause a temporary change in ion permeability of the tissue cell membranes and a depolarization of the tissue cells. | 02-17-2011 |
Annika Oettl, Kassel DE
Patent application number | Description | Published |
---|---|---|
20130026379 | DIRECT CONVERSION X-RAY DETECTOR WITH RADIATION PROTECTION FOR ELECTRONICS - The present invention relates to an X-ray detector having an X-ray sensor (first X-ray sensor) converting X-radiation directly into electric charge carriers, having signal evaluation electronics electrically connected to the X-ray sensor and preferably formed as integrated circuit(s), having an X-ray absorber formed for protecting the signal evaluation electronics, and having a sensor carrier (first sensor carrier) formed and arranged for positioning the X-ray sensor relative to the X-ray absorber, wherein, viewed in the direction of incidence of the X-radiation, both the signal evaluation electronics are arranged behind the X-ray absorber and in the X-radiation shadow thereof and the X-ray sensor is admittedly likewise positioned by means of the sensor carrier preferably arranged between the X-ray absorber and the signal evaluation electronics at least sectionally behind the X-ray absorber, but outside the X-radiation shadow thereof. | 01-31-2013 |
Annika Schmid, Neuried DE
Patent application number | Description | Published |
---|---|---|
20140377281 | LECTIN-LIKE OXIDIZED LDL RECEPTOR 1 ANTIBODIES AND METHODS OF USE - The present invention relates to monoclonal antibodies binding to human lectin-like oxidized LDL (low density lipoprotein) receptor 1 (hereinafter, sometimes referred to as “LOX-1”), and pharmaceutical compositions and methods of treatment comprising the same. | 12-25-2014 |
Annika Schmidt, Runkel DE
Patent application number | Description | Published |
---|---|---|
20110077157 | Oil Suspension Concentrate - The present invention relates to an oil suspension concentrate comprising | 03-31-2011 |
Annika Smedberg, Myggenaes SE
Patent application number | Description | Published |
---|---|---|
20080308296 | Polyolefin Composition For Use As An Insulating Material - The invention relates to a polymer composition, comprising (a) a polyolefin base resin which comprises at least (a1) a first olefin homo- or copolymer fraction, and (a2) a second olefin homo- or copolymer fraction, wherein the weight average molecular weight of the first fraction is lower than the weight average molecular weight of the second fraction, and (b) at least one additive selected from a polar copolymer; a low density polyethylene; an ether and/or ester group containing additive selected from the group consisting of polyethylene glycol, a glycerol ester compound, polypropylene glycol, an amido group containing fatty acid ester, ethoxylated and/or propoxylated pentaerythritol, an alpha-tocopherol ester, an ethoxylated and/or propoxylated fatty acid, and derivatives thereof; or mixtures of these additives. | 12-18-2008 |
20090029166 | POLYMER COMPOSITION HAVING IMPROVED WET AGEING PROPERTIES - The present invention relates to a crosslinkable polymer composition, comprising (i) an unsaturated polyolefin having a total amount of carbon-carbon double bonds/1000 carbon atoms of more than 0.37, and (ii) a polar copolymer | 01-29-2009 |
20110061893 | WATER TREE RETARDING COMPOSITION - The present invention relates to a crosslinkable polymer composition, comprising (i) an unsaturated polyolefin having a total amount of carbon-carbon double bonds/1000 carbon atoms of more than 0.37, and (ii) at least one ether and/or ester group containing additive selected from the group consisting of polyethylene glycol, a glycerol ester compound, polypropylene glycol, an amido group containing fatty acid ester, ethoxylated and/or propoxylated pentaerythritol, an alpha-tocopherol ester, an ethoxylated and/or propoxylated fatty acid, and derivatives thereof. | 03-17-2011 |
Annika Sörfeldt, Hisings Karra SE
Patent application number | Description | Published |
---|---|---|
20110119768 | COMMUNICATION ARRANGEMENT - The present invention relates to a method, node and system for efficient handling of sharing a set of data and in particular where the data set is shared in a volatile manner. Each node with access to the data set sharing group controls the access of data set from the node and each node stores data set received from other nodes in the group in a volatile manner providing removal of data set received from a node that has left the sharing group. | 05-19-2011 |
Annika Stobrawe, Dormagen DE
Patent application number | Description | Published |
---|---|---|
20120101216 | METHOD FOR PRODUCING POLYMERIC SOLIDS - The invention relates to a method for producing polymeric solids free of auxiliary emulators starting from polymer latices (dispersion), wherein a polymer dispersion with a starting ph-value greater than 9 is set to a ph-value of 6 to 9 by adding gaseous carbon dioxide and the polymer dispersion is subsequently coagulated by shearing and/or freezing. | 04-26-2012 |
Annika Tallsjo, Uppsala SE
Patent application number | Description | Published |
---|---|---|
20090155801 | METHOD OF SEQUENCING DNA - The present invention provides a method of identifying a base at a target position in a sample nucleic acid sequence, said method comprising: subjecting a primer hybridised to said sample nucleic acid immediately adjacent to the target position, to a polymerase primer extension reaction in the presence of a nucleotide, whereby the nucleotide will only become incorporated if it is complementary to the base in the target position, and determining whether or not said nucleotide is incorporated by detecting whether PPi is released, the identity of the target base being determined from the identity of any nucleotide incorporated, wherein, where said nucleotide comprises an adenine base, an α-thio triphosphate analogue of said nucleotide is used, ant the Rp isomer of said analogue and/or the degradation products of said analogue are eliminated from the polymerase reaction step. | 06-18-2009 |
Annika Trosin, Recklinghausen DE
Patent application number | Description | Published |
---|---|---|
20140274863 | PHOSPHORIC ACID ESTERS, THEIR PREPARATION AND USE - The invention relates to phosphoric acid esters of polyether-modified alkyl alcohols, to their preparation and to a use of phosphoric acid esters of polyether-modified alkyl alcohols for generating shine on a surface. | 09-18-2014 |